Press release
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia - Drug Pipeline Landscape
Fibromyalgia can be diagnosed if the patient had widespread pain for 3 months or longer. Healthcare professionals use a process of elimination to diagnose fibromyalgia, for concluding that no other condition is causing the pain. Healthcare professionals may rule out other conditions that may have similar symptoms with some tests including complete blood count, Rheumatoid factor, thyroid function tests, anti-nuclear antibody, cyclic citrullinated peptide test etc.
Read more about Fibromyalgia - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/
Report Highlights:
Global Insight Service's, Fibromyalgia - Drug Pipeline Landscape, 2022 report provides an overview of the Fibromyalgia pipeline drugs. This report covers detailed insights on Fibromyalgia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Fibromyalgia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology:
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31036/
Scope:
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Key Players:
- Aardvark Therapeutics Inc
- Aptinyx
- Astellas Pharma Inc
- Cortene Inc
- Shanghai lvdao pharmaceutical technology co., Ltd
- Pfizer
- Tonix Pharmaceuticals, Inc.
- TRYP Therapeutics
Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31036/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibromyalgia - Drug Pipeline Landscape, 2022 here
News-ID: 2697716 • Views: …
More Releases from Global Insight Services
Handmade Jewelry Market Expected to Grow from $203.8 Billion in 2024 to $594.3 B …
The Handmade Jewelry Market has emerged as a vibrant and fast-growing sector, driven by the rising consumer preference for artisanal, personalized, and ethically produced accessories. Handmade jewelry encompasses a wide array of products, including necklaces, bracelets, earrings, rings, and other unique adornments, often crafted using precious metals, gemstones, and innovative materials. Unlike mass-produced jewelry, handmade pieces resonate with consumers seeking individuality, sustainability, and artistic expression. The market benefits greatly from…
Gene Silencing Market Expected to Grow from $4.66 Billion in 2024 to $11.31 Bill …
The Gene Silencing Market is emerging as one of the most promising areas in biotechnology and medical research. By using advanced tools to suppress gene expression, scientists can better understand genetic functions and design treatments for diseases at their roots. Techniques such as RNA interference (RNAi), antisense oligonucleotides, and CRISPR-based approaches have broadened the scope of applications, from therapeutic innovations to agricultural advancements. This market not only reflects the cutting…
Risk Management Software Market Is Anticipated To Expand From $14.9 Billion In 2 …
Market Overview
The Risk Management Software Market is becoming an essential pillar for organizations across industries as they navigate an increasingly complex business environment. Companies face rising challenges ranging from regulatory compliance and cybersecurity threats to operational inefficiencies and supply chain disruptions. Risk management software provides a unified solution to identify, monitor, and mitigate these risks, enabling organizations to make informed decisions while safeguarding business continuity. These tools are not limited…
Rare Disease Treatment Market Expected to Grow from $213.5 Billion in 2024 to $5 …
The Rare Disease Treatment Market is emerging as one of the most dynamic sectors in the global healthcare landscape. This market focuses on the development, production, and distribution of therapies designed to address rare and complex medical conditions affecting a small percentage of the population. Rare diseases, often genetic in origin, pose significant treatment challenges, which has prompted biopharmaceutical companies to invest in innovative solutions such as orphan drugs, gene…
More Releases for Fibromyalgia
Government Initiatives On Musculoskeletal Health Propel Growth In The Fibromyalg …
The Fibromyalgia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Fibromyalgia Treatment Market?
The market for the treatment of fibromyalgia has been expanding consistently in past years. At a compound annual growth rate (CAGR) of 3.9%, it is…
SN Clinic's Effective Treatment of Fibromyalgia Symptoms
Image: https://www.globalnewslines.com/uploads/2025/02/1740408683.jpg
SN Clinic Logo
Fibromyalgia can be a debilitating condition, but SN Clinic offers hope through innovative treatments like MLS Laser Therapy and complementary massage therapies. By addressing chronic pain through a holistic approach, patients can experience significant relief and an improved quality of life.
What is Fibromyalgia and What Does Current Data Say?
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Affecting…
Prominent Fibromyalgia Treatment Market Trend for 2025: Market Leaders Focus On …
What Are the Projected Growth and Market Size Trends for the Fibromyalgia Treatment Market?
The Fibromyalgia Treatment market is expected to grow from $2.79 billion in 2024 to $2.9 billion in 2025, at a CAGR of 3.9%. This growth is attributed to the increasing prevalence of fibromyalgia, greater awareness about the condition, government initiatives, and rising disposable incomes.
The fibromyalgia treatment market is projected to see steady growth, reaching $3.45 billion by…
Advancements in Fibromyalgia Treatments Driving Market Expansion
The fibromyalgia treatment market is experiencing a steady upward trajectory, with significant growth expected over the next decade. Estimated at USD 2.77 billion in 2023, the market is projected to reach approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032. This expansion is driven by several key factors, including advances in treatment options, increasing demand for effective therapies, and…
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues.
Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD.
To know more about Fibromyalgia - Drug Pipeline, visit - https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/
Fibromyalgia…
Fibromyalgia Treatment Market 2022 | Increased Morbidity of Fibromyalgia Along w …
According to Precision Business Insights (PBI), the latest report, the Fibromyalgia Treatment market is expected to be valued at USD 3,017.9 million in 2022, growing at an 3.8% CAGR from 2022 to 2028. Fibromyalgia treatment market analysis projects that the increased prevalence of fibromyalgia and its related complication compelled the introduction of targeted & precise treatment methods for fibromyalgia. Also, the increase in awareness about fibromyalgia will give the required…
